Stay ahead of the curve with curated content from across the advanced therapies industry. From breaking news and regulatory updates to expert interviews and event highlights.
)
Advancing Cell and Gene Therapy Development Through Innovation and Collaboration
At Advanced Therapies Week 2025, Fresenius Kabi joined AT-TV to showcase how their cell processing platforms are enabling scalable and automated manufacturing for cell and gene therapies. With a focus on flexibility, innovation, and strategic partnerships, their team discusses solutions designed to meet current and future manufacturing demands.
)
Bionova Scientific Launches State-of-the-Art Plasmid DNA Facility in The Woodlands
At Advanced Therapies Week 2025, Bionova Scientific announced the opening of a dedicated plasmid DNA manufacturing facility in The Woodlands, Texas. In this AT-TV interview, Chief Scientific Officer Jesse McCool details Bionova Scientific's expansion into advanced therapies and their plans to integrate plasmid DNA and viral vector capabilities for gene therapy developers.
)
Bridging Gaps in Scalability and Cold Chain Logistics for Tomorrow’s Advanced Therapies
As cell and gene therapies evolve, so too must the logistics that support them. In this insightful AT-TV episode, Ben McLoud speaks with Rohan Iyer of Marken to explore the future of cold chain logistics, real-time monitoring, and scalability in the advanced therapies industry. Filmed at Advanced Therapies Week 2025, this conversation sheds light on the strategies shaping tomorrow's supply chains.
)
CGT Game Changer: Visualizing Cell Metabolism Changes in Real Time with LiCellMo
At Advanced Therapies Week 2025, PHC Corporation of North America introduced LiCellMo™, a live cell metabolic analyzer designed to visualize real-time metabolic changes in cell cultures. In this AT-TV interview, PHC executives and product specialists explain how this technology is advancing research in cancer immunology, stem cells, and cell therapy manufacturing.
)
Charles River Laboratories Launches Global Biotech Incubator Program
At Advanced Therapies Week 2025, Charles River Laboratories introduced its new global biotech incubator and accelerator program aimed at supporting emerging cell and gene therapy developers. In this AT-TV interview, Kirsten Dolph, Senior Vice President of Global Manufacturing, shares how the initiative helps startups overcome common hurdles on the path to commercialization.
)
Driving Innovation in Life Sciences: A Journey of Growth and Connection
At Advanced Therapies Week 2025, Emerson’s life sciences team joined AT-TV to discuss how their technologies are supporting advanced therapies manufacturing. Emerson’s Michalle Adkins and Nikki Bishop explain how digital workflows, flexible manufacturing, and data capture solutions are addressing key industry challenges, from pipeline acceleration to operational sustainability.
)
Embracing Innovation to Fight the Good Fight: Lowering the Costs of Viral Vector Manufacture
At Advanced Therapies Week 2025, ProteoNic joined AT-TV to discuss their efforts to reduce the cost of viral vector manufacturing through innovation in genetic engineering. Shalinee Khadun, Director of Business Development, explains how their technology is increasing viral vector yields and why industry collaboration is key to making advanced therapies more accessible.
)
Empowering Innovation: Women Leading the Way in Advanced Therapies
At Advanced Therapies Week 2025, three experienced women in biotech came together to discuss leadership, innovation, and diversity in advanced therapies. In this AT-TV interview, Carol Houts, Alyssa Waid, and Priya Baraniak share personal stories and practical advice for building careers and advancing the cell and gene therapy field.
)
Latest Innovations from Cryoport Systems Enable Exceptional Patient Outcomes
Filmed at Advanced Therapies Week 2025, this AT-TV interview features Aruna Mor, Michael Dybicz, and Matthew Frazzetta of Cryoport Systems as they discuss innovations in cryogenic packaging, bioservices, and regulatory support. Learn how their patient-centric, end-to-end platform is addressing the critical logistical needs of advanced therapy developers worldwide.
)
Overcoming manufacturing challenges for advanced therapies
Manufacturing advanced therapies remains a complex and costly endeavor. In this AT-TV interview from Advanced Therapies Week 2025, Rachel Legmann, Senior Director of Technology at Repligen, explores the persistent challenges in viral vector manufacturing and shares strategies to streamline processes, reduce costs, and enhance scalability for cell and gene therapy developers.
)
Redefining Manufacturing: OmniaBio’s New Commercial CDMO Facility
At Advanced Therapies Week 2025, OmniaBio unveiled how its newly launched commercial CDMO facility in Hamilton, Canada, is reshaping manufacturing for advanced therapies. In this AT-TV interview, CEO Mitchel Sivilotti explains how robotics, AI, and real-time data collection are reducing costs and increasing access to cell and gene therapies.
)
Redefining white glove delivery for cell and gene therapy
At Advanced Therapies Week 2025, Cardinal Health shared how they are redefining white glove delivery for cell and gene therapy developers. Their patient-first logistics model eliminates complexity, improves hospital access, and ensures therapies reach patients on time—every time.